Feedback
Settings

Settings

Goto Application

1. US20210169996 - Treatment of Glycogen Storage Disease Type II

PermaLink
Office
United States of America
Application Number 16940054
Application Date 27.07.2020
Publication Number 20210169996
Publication Date 10.06.2021
Publication Kind A1
IPC
A61K 38/47
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
43Enzymes; Proenzymes; Derivatives thereof
46Hydrolases (3)
47acting on glycosyl compounds (3.2), e.g. cellulases, lactases
A61K 45/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
CPC
A61K 38/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
A61K 38/47
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
43Enzymes; Proenzymes; Derivatives thereof
46Hydrolases (3)
47acting on glycosyl compounds (3.2), e.g. cellulases, lactases
C12Y 302/0102
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
YENZYMES
302Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
0102Alpha-glucosidase (3.2.1.20)
A61K 45/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Applicants Duke University
Inventors Yuan-Tsong Chen
Title
(EN) Treatment of Glycogen Storage Disease Type II
front page image
Abstract
(EN)

Methods of treating glycogen storage disease type II, by administering acid α-glucosidase, are described, as are compositions for use in treatment of glycogen storage disease type II.
Related patent documents
BRPI0113006
EP1301201
EP1782825
CA2416492
DE000060126947
EP2767291
PT1301201
ES2523024
PT1782825
AU2001271941
EP3108895
DK1301201
DK1782825
DK2767291
ES2599401
PT2767291
DK3108895
WO/2002/005841
ES2277931
US20020110551
LT2767291
ES2700865
LT3108895
EP3449934
JP2004503598
PT3108895
DK3449934
PT3449934
LT3449934
ES2799882
AT355075
MXPA/a/2003/000474
US20050123531
AU2007202469
US20080175833
JP2008081507
US20100254966
AU2010200487
US20120058132
AU2011204991
JP2012006953
US20130195834
AU2012216860
JP2013231081
JP2014185187
US20150004152
AU2015202140
JP2016056206
US20160184410
AU2016256663
JP2017137357
JP2018002749
US20180185457
JP2018199721
AU2018247261
JP2020019822
# -